Young Matthew P.

CytomX Therapeutics, Inc. · Director

Young Matthew P. is listed in filings as Director at CytomX Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 13, 2025, including 1 public disclosure. Recent filings connect the profile to CytomX Therapeutics, Inc. (CTMX). The current snapshot covers public activity from Jun 13, 2025. Reported amounts are shown as $107.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.